Seminar: «Current topics in Pharmacology and Theranostics»

Seminarraum INO-F 703, Institut für Pharmakologie

Datum Zeit Name   Titel Gastgeber 
Jan 19, 2018 12:15  Prof. Dr. Daniel Hoessli, Panjwani Center for Molecular Medicine and Drug Design, University of Karachi, Pakistan

Modulation of resistance to tyrosine kinase inhibitors

H.- U. Simon 
Feb 14, 2018 12:15 PD Dr. Remo Perozzo, Senior Lecturer and Research Associate (MER), School of Pharmaceutical Sciences, University of Geneva Development of a novel bacterial three-hybrid system: A feasibility study H.- U. Simon 
Feb 28, 2017 12:15 Dr. Isabelle Arnold, Institute of Molecular Cancer Research, University of Zurich Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation  H.- U. Simon 
Mar 13, 2018 16:00 Prof. Guy Gorochov, Head of Department of Immunology, Co-director, CIMI research centre, Paris, France  Metagenome-wide analysis of gut microbiota in human IgA deficiency S. von Gunten 
Mar 21, 2018 12:15 Dr. Melita Irving, Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne T-Cell Engineering Approaches for Improving Cancer Immunotherapy S. von Gunten  
Mar 28, 2018 12:15  Prof. Dr. Jan Hendrik Niess, Universitätsspital Basel, Gastroenterologie und Hepatologie IL-20 Cytokines in Intestinal Diseases  H.- U. Simon
April 18, 2018 12:15 Prof. Dr. Richard Cummings, Harvard Medical School, Boston, USA  Glycosylation is Required for Leukocyte Trafficking and Function in Immune Recognition S. von Gunten  
May 16, 2018 12:30  Prof. Csaba Szabo, MD, PhD, D.Sc., Department of Pharmacology, University of Fribourg The vascular roles of H2S in health and disease A. Huwiler
May 30, 2018  12:15  Dr. Christoph Esslinger, CEO Memo Therapeutics AG MemoMAB: Gateway to human antibody repertoires S. von Gunten
July 25, 2018 12:15 Prof. Dr. Edward Pearce, Max Planck Institute of Immunobiology and Epigenetics and University of Freiburg, Freiburg, Germany Title to be announced H.- U. Simon 
Sep 26, 2018  12:15 Dr. Alexander Lämmle, Universitätsklinik für Kinderheilkunde und Universitätsinstitut für Kinische Chemie, Inselspital, University of Bern Liver disease modeling using iPSC-derived hepatocytes H.- U. Simon 

Unterstützt durch:

Pfizer AG, Zürich

Weitere potentielle Sponsoren melden sich bitte bei Prof. Simon